Business

Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device

RA'ANANA, Israel, Jan. 2, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a

articleQtrex Quantum Ltd.January 2, 20245/company/inspira-technologies-oxy-bhn-ltd/news/inspiratm-technologies-signs-letter-of-intent-with-northwestern-memorial-hospital-in-chicago-for-clinical-use-of-inspiratm-art100-device
Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device

About this update from Qtrex Quantum Ltd.

[{"type":"text","content":"RA'ANANA, Israel, Jan. 2, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the \"Company\" or \"Inspira Technologies\"), a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, has announced the signing of a non-binding Letter of Intent (LOI) with Northwestern Memorial Hospital in Chicago, Illinois (\"Northwestern\"). Northwestern, ranked as the eighth best hospital in the United States by Newsweek in 2023, is part of Northwestern Medicine, which operates several hospitals in the United States. \n\nThe LOI expresses the mutual interest by both parties to further explore potential collaboration regarding the evaluation of how the INSPIRA ART100 device (\"Device\" or \"Devices\") aligns with Northwestern's needs in clinical scenarios, workflow efficiency, and healthcare delivery. Northwestern will also agree to purchase all necessary disposables to operate the Devices and will, in turn, provide Inspira Technologies with valuable data and Device diagnostics from its usage. The terms of the agreement contemplated by the LOI are subject to U.S. Food & Drug Administration (\"FDA\") clearance of the Device in the first half of 2024 as well as the parties entering a definitive evaluation agreement.\nJoe Hayon, President of Inspira Technologies, commented: \"We believe that an opportunity to evaluate the INSPIRA ART100 with a leading hospital, such as Northwestern, may evolve into a significant route to entering the healthcare market in the U.S.\"\nAbout Northwestern Memorial Hospital \nNorthwestern Memorial Hospital (\"Northwestern\"), based in Chicago, is a leading academic medical center. Northwestern has earned significant recognition on the U.S. News & World Report's \"America's Best Hospitals\" list for 2023. Recognized as the seventh most prestigious institution in cardiology, heart & vascular Surgery and the eighteenth most prestigious institution in pulmonology & lung surgery, Northwestern is also a large lung transplant center. Northwestern achieved recognition as a Gold Level Extracorporeal Life Support Organization Center of Excellence.\nInspira Technologies OXY B.H.N Ltd.\nInspira Technologies is leading the way in transforming life-support care. Its innovative solutions are paving the way for direct blood oxygenation, bypassing the lungs, an...

More updates from Qtrex Quantum Ltd.